Investment
Features
FeesSafety
Academy
More
Pluang+

Eat Well appoints Matthew Anderson as new CFO, replacing Patrick Dunn who resigned.

Market News
20 Oct 2026
Newsfile Corp
View Source
Neutral
Eat Well appoints Matthew Anderson as new CFO, replacing Patrick Dunn who resigned.

Eat Well Investment Group announced the resignation of Patrick Dunn as Chief Financial Officer and Director, effective October 16, 2026. Matthew Anderson, a seasoned CPA with over 20 years of experience and Managing Director at Malaspina Consultants, has been appointed as the new CFO. Anderson has been involved with Eat Well's financial reporting since July 2025 and played a key role in updating the company's disclosures. This leadership change aims to support Eat Well's continued growth in the agricultural and food infrastructure sector across North America.

Regarding the Eat Well Investment Group's CFO appointment, here is Pluang's market snapshot as of Oct 21, 2026 01:51 WIB: Among 150 priced US stocks tradable on Pluang, 110 rose and 40 fell today. Notable movers include Moderna, Inc. (MRNA) at USD 241.31 with a 6.36% increase and a typical hold time of 59 days, Li Auto Inc (LI) at USD 11.99 up 6.20% with a 102-day hold, and Novavax Inc (NVAX) at USD 11.45 rising 5.82% with a 59-day hold time. Pluang order activity varies, for example, MRNA shows 40% sell and 60% buy orders.

More News

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
Brunello Cucinelli raises 2026 outlook after strong Q3 sales, Citigroup keeps Buy rating.

Brunello Cucinelli raises 2026 outlook after strong Q3 sales, Citigroup keeps Buy rating.

Brunello Cucinelli, an Italian luxury fashion company, raised its 2026 outlook following stronger-than-expected third-quarter sales. Citigroup maintains a Buy rating on the stock, which trades around $9.43 with a market cap of approximately $6.41 bil...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App